Uploaded June 2026 | Updated September 2026, 3 days ago
Prof. Eberhard Standl joins EASD TV to mark a remarkable milestone: 50 years since attending his first EASD Congress.
Reflecting on a career spanning five decades, Prof. Standl discusses how diabetes care has evolved from the management of diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, immunotherapies, and the possibility of reversing type 2 diabetes.
The conversation explores the importance of lifestyle interventions, exercise, patient-clinician partnerships, and the future of diabetes treatment. Prof. Standl also shares insights into emerging research linking diabetes, obesity, metabolism, and cancer, as well as ongoing efforts to preserve insulin production and ultimately achieve cures for type 1 diabetes.
Subscribe for more interviews, scientific highlights and expert perspectives from EASD 2025.
Prof. Eberhard Standl joins EASD TV to mark a remarkable milestone: 50 years since attending his first EASD Congress.
Reflecting on a career spanning five decades, Prof. Standl discusses how diabetes care has evolved from the management of diabetic ketoacidosis in the 1970s to today's advances in continuous glucose monitoring, hybrid closed-loop systems, immunotherapies, and the possibility of reversing type 2 diabetes.
The conversation explores the importance of lifestyle interventions, exercise, patient-clinician partnerships, and the future of diabetes treatment. Prof. Standl also shares insights into emerging research linking diabetes, obesity, metabolism, and cancer, as well as ongoing efforts to preserve insulin production and ultimately achieve cures for type 1 diabetes.
Subscribe for more interviews, scientific highlights and expert perspectives from EASD 2025.
